MCK:NYSEMcKesson Corporation Analysis
Data as of 2026-03-09 - not real-time
$942.16
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
McKesson is trading well above its short‑term support but still below its long‑term moving averages, indicating a bullish bias despite a recent bearish MACD crossover. The stock’s price is comfortably under its discounted cash‑flow fair‑value estimate, suggesting a modest upside, while the RSI hovers around the mid‑50s, reflecting neutral momentum. Revenue growth remains double‑digit and cash flow generation is strong, supporting the current dividend with a very low payout ratio. Recent market sentiment is highly positive, as reflected by an “Extreme Greed” reading on the fear‑greed index, and analyst coverage leans toward a buy recommendation.
Overall, the combination of solid fundamentals, attractive valuation relative to intrinsic value, and a defensive dividend profile makes MCK a compelling hold with upside potential, provided investors stay mindful of short‑term technical headwinds.
Overall, the combination of solid fundamentals, attractive valuation relative to intrinsic value, and a defensive dividend profile makes MCK a compelling hold with upside potential, provided investors stay mindful of short‑term technical headwinds.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support but above key moving averages
- Bearish MACD histogram indicating short‑term downside pressure
- Stable trading volume limiting abrupt moves
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth outpacing industry peers
- DCF fair‑value indicates modest upside
- Low beta and defensive dividend support risk‑adjusted returns
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strong cash‑flow generation and low payout ratio
- Strategic position in healthcare distribution with secular demand
- Undervalued relative to intrinsic value and favorable long‑term industry dynamics
Key Metrics & Analysis
Financial Health
Revenue Growth11.40%
Profit Margin1.09%
P/E Ratio27.2
ROA4.33%
P/B Ratio-89.3
Op. Cash Flow$10.5B
Free Cash Flow$9.2B
Industry P/E25.4
Technical Analysis
TrendBullish
RSI52.9
Support$894.59
Resistance$999.00
MA 20$953.47
MA 50$882.99
MA 200$783.61
MACDBearish
VolumeStable
Fear & Greed Index75.89
Valuation
Fair Value$1,614.35
Target Price$995.27
Upside/Downside5.64%
GradeUndervalued
TypeBlend
Dividend Yield0.36%
Risk Assessment
Beta0.13
Volatility53.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.